
Bloomberg Businessweek
Bloomberg Markets: Adviser Backs Dumping Mylan Board
10 min•12 juni 2017
Om avsnittet
Bloomberg Markets with Carol Massar and Cory Johnson. GUEST: Cynthia Koons Healthcare Reporter Bloomberg News Discussing Mylan NV facing an increasing backlash over its handling of the EpiPen pricing controversy, as a top proxy adviser urged shareholders to oust the drugmaker’s board.
See omnystudio.com/listener for privacy information.
Fler avsnitt
Visa alla avsnitt av Bloomberg BusinessweekBloomberg Businessweek med Bloomberg finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.